Patents by Inventor Robin M. Jackman

Robin M. Jackman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NANOPARTICLE COMPOSITIONS
    Publication number: 20230099727
    Abstract: Provided herein are nanoparticle compositions comprising a pharmaceutically acceptable carrier and a compound of Formula (II).
    Type: Application
    Filed: January 12, 2021
    Publication date: March 30, 2023
    Inventors: Raj RAHEJA, Robin M. JACKMAN, Jason A. KAHANA
  • Nanoparticle compositions
    Patent number: 11306399
    Abstract: Provided herein are nanoparticle compositions comprising an organophosphate compound and pharmaceutically acceptable carriers.
    Type: Grant
    Filed: August 12, 2020
    Date of Patent: April 19, 2022
    Assignee: JANUARY THERAPEUTICS, INC.
    Inventors: Raj Raheja, Robin M. Jackman, Jason A. Kahana
  • Organophosphate derivatives
    Patent number: 11306111
    Abstract: Provided herein are organophosphates and pharmaceutical compositions comprising said compounds.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: April 19, 2022
    Assignee: JANUARY THERAPEUTICS, INC.
    Inventors: Raj Raheja, Robin M. Jackman
  • NANOPARTICLE COMPOSITIONS
    Publication number: 20210299273
    Abstract: Provided herein are nanoparticle compositions comprising a pharmaceutically acceptable carrier and a compound of Formula (I): A-L-B.
    Type: Application
    Filed: July 23, 2019
    Publication date: September 30, 2021
    Inventors: Raj RAHEJA, Robin M. JACKMAN, Jason A. KAHANA
  • NANOPARTICLE COMPOSITIONS
    Publication number: 20210047358
    Abstract: Provided herein are nanoparticle compositions comprising an organophosphate compound and pharmaceutically acceptable carriers.
    Type: Application
    Filed: August 12, 2020
    Publication date: February 18, 2021
    Inventors: Raj RAHEJA, Robin M. JACKMAN, Jason A. KAHANA
  • NANOPARTICLE COMPOSITIONS
    Publication number: 20210038628
    Abstract: Provided herein are nanoparticle compositions comprising organophosphate compounds, and pharmaceutically acceptable carriers.
    Type: Application
    Filed: March 1, 2019
    Publication date: February 11, 2021
    Applicant: January Therapeutics, Inc.
    Inventors: Raj RAHEJA, Robin M. JACKMAN, Jason A. KAHANA
  • METHODS OF DIAGNOSING A DISEASE AND METHODS OF MONITORING TREATMENT OF A DISEASE BY QUANTIFYING A NON-REDUCING END GLYCAN RESIDUAL COMPOUND AND COMPARING TO A SECOND BIOMARKER
    Publication number: 20210025874
    Abstract: Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.
    Type: Application
    Filed: May 8, 2020
    Publication date: January 28, 2021
    Applicant: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Brett E. CRAWFORD, Jillian R. BROWN, Charles A. GLASS, Jim R. BEITEL, Robin M. JACKMAN
  • NANOPARTICLE COMPOSITIONS
    Publication number: 20210007999
    Abstract: This disclosure provides nanoparticle compositions comprising nucleoside or nucleotide prodrugs, their use as medicinal agents, and processes for their preparation. The disclosure also provides for the use of the nanoparticle compositions described herein as medicaments and/or in the manufacture of medicaments for the treatment of a variety of diseases, including cancer and viral infections. Provided in one aspect is a composition comprising nanoparticles, wherein the nanoparticles comprise a prodrug of a nucleoside or nucleotide, and a pharmaceutically acceptable carrier; wherein the pharmaceutically acceptable carrier comprises albumin.
    Type: Application
    Filed: March 1, 2019
    Publication date: January 14, 2021
    Inventors: Raj RAHEJA, Robin M. JACKMAN, Jason A. KAHANA
  • NANOPARTICLE COMPOSITIONS
    Publication number: 20210008076
    Abstract: Provided herein are nanoparticle compositions comprising modulators of the Bcl-2 family proteins, and pharmaceutically acceptable carriers.
    Type: Application
    Filed: March 15, 2019
    Publication date: January 14, 2021
    Inventors: Raj RAHEJA, Robin M. JACKMAN, Jason A. KAHANA
  • ORGANOPHOSPHATE DERIVATIVES
    Publication number: 20200369695
    Abstract: Provided herein are organophosphates and pharmaceutical compositions comprising said compounds.
    Type: Application
    Filed: July 30, 2018
    Publication date: November 26, 2020
    Inventors: Raj RAHEJA, Robin M. Jackman
  • Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
    Patent number: 10793894
    Abstract: Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: October 6, 2020
    Assignee: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Brett E. Crawford, Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman
  • Methods of diagnosing mucopolysaccharidosis (MPS) I and methods of monitoring treatment of MPS by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
    Patent number: 10677786
    Abstract: Provided herein are methods of diagnosing or monitoring the treatment of mucopolysaccharidosis (MPS) I or a disorder associated with MPS I.
    Type: Grant
    Filed: February 8, 2018
    Date of Patent: June 9, 2020
    Assignee: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Brett E. Crawford, Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman
  • QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS FOR DETERMINING THE PRESENCE, IDENTITY, OR SEVERITY OF A DISEASE OR CONDITION
    Publication number: 20190249224
    Abstract: Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.
    Type: Application
    Filed: February 20, 2019
    Publication date: August 15, 2019
    Applicant: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Brett E. CRAWFORD, Jillian R. BROWN, Charles A. GLASS, Jim R. BEITEL, Robin M. JACKMAN
  • Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
    Patent number: 10260084
    Abstract: Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.
    Type: Grant
    Filed: May 12, 2017
    Date of Patent: April 16, 2019
    Assignee: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Brett E. Crawford, Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman
  • METHODS OF DIAGNOSING A DISEASE AND METHODS OF MONITORING TREATMENT OF A DISEASE BY QUANTIFYING A NON-REDUCING END GLYCAN RESIDUAL COMPOUND AND COMPARING TO A SECOND BIOMARKER
    Publication number: 20180259507
    Abstract: Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.
    Type: Application
    Filed: February 8, 2018
    Publication date: September 13, 2018
    Inventors: Brett E. CRAWFORD, Jillian R. BROWN, Charles A. GLASS, Jim R. BEITEL, Robin M. JACKMAN
  • Methods of determining the presence, identity, and/or severity of mucopolysaccharidosis (MPS) VI and IVA
    Patent number: 9915649
    Abstract: Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.
    Type: Grant
    Filed: April 12, 2016
    Date of Patent: March 13, 2018
    Assignee: BIOMARIN PHARMACEUTICALS INC.
    Inventors: Brett E. Crawford, Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman
  • QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS FOR DETERMINING THE PRESENCE, IDENTITY, OR SEVERITY OF A DISEASE OR CONDITION
    Publication number: 20170321246
    Abstract: Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.
    Type: Application
    Filed: May 12, 2017
    Publication date: November 9, 2017
    Inventors: Brett E. CRAWFORD, Jillian R. BROWN, Charles A. GLASS, Jim R. BEITEL, Robin M. JACKMAN
  • Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
    Patent number: 9677116
    Abstract: Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.
    Type: Grant
    Filed: December 1, 2015
    Date of Patent: June 13, 2017
    Assignee: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Brett E. Crawford, Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman
  • METHODS OF DIAGNOSING A DISEASE AND METHODS OF MONITORING TREATMENT OF A DISEASE BY QUANTIFYING A NON-REDUCING END GLYCAN RESIDUAL COMPOUND AND COMPARING TO A SECOND BIOMARKER
    Publication number: 20160327548
    Abstract: Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.
    Type: Application
    Filed: April 12, 2016
    Publication date: November 10, 2016
    Inventors: Brett E. Crawford, Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman
  • QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS FOR DETERMINGING THE PRESENCE, IDENTITY, OR SEVERITY OF A DISEASE OR CONDITION
    Publication number: 20160153024
    Abstract: Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.
    Type: Application
    Filed: December 1, 2015
    Publication date: June 2, 2016
    Inventors: Brett E. Crawford, Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman